Tumour immunology - present status and lessons from the 1st International Conference on Basic and Clinical Immunogenomics. Part II - Tumour immunotherapy
2005
Abstract
Tha activation of the immune system may represent a therapeutic modality to cancer. This can be achieved either by therapeutic vaccination or by supplementation of activated immune effectors like antibodies or activated immunocompetent cells.